Bridgepoint Group (LON:BPT) Stock Price Down 0.1%

Bridgepoint Group plc (LON:BPTGet Free Report) shares dropped 0.1% during mid-day trading on Wednesday . The company traded as low as GBX 224.20 ($2.77) and last traded at GBX 226.80 ($2.80). Approximately 233,607 shares changed hands during mid-day trading, a decline of 13% from the average daily volume of 268,447 shares. The stock had previously closed at GBX 227 ($2.80).

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. reduced their price target on shares of Bridgepoint Group from GBX 262 ($3.24) to GBX 259 ($3.20) and set a “neutral” rating on the stock in a report on Wednesday, April 3rd.

Check Out Our Latest Report on Bridgepoint Group

Bridgepoint Group Stock Down 0.1 %

The company has a debt-to-equity ratio of 15.27, a current ratio of 5.32 and a quick ratio of 3.60. The firm’s 50-day moving average is GBX 258.96 and its 200 day moving average is GBX 244.49. The stock has a market cap of £1.80 billion, a price-to-earnings ratio of 2,520.00, a price-to-earnings-growth ratio of 0.61 and a beta of 1.64.

Bridgepoint Group Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Tuesday, May 21st. Stockholders of record on Thursday, April 18th will be given a GBX 4.40 ($0.05) dividend. This represents a dividend yield of 1.68%. The ex-dividend date of this dividend is Thursday, April 18th. Bridgepoint Group’s payout ratio is currently 10,000.00%.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

Further Reading

Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.